» Articles » PMID: 23483116

Neuro-Genetics of Reward Deficiency Syndrome (RDS) As the Root Cause of "Addiction Transfer": A New Phenomenon Common After Bariatric Surgery

Overview
Date 2013 Mar 14
PMID 23483116
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Now after many years of successful bariatric (weight-loss) surgeries directed at the obesity epidemic clinicians are reporting that some patients are replacing compulsive overeating with newly acquired compulsive disorders such as alcoholism, gambling, drugs, and other addictions like compulsive shopping and exercise. This review article explores evidence from psychiatric genetic animal and human studies that link compulsive overeating and other compulsive disorders to explain the phenomenon of addiction transfer. Possibly due to neurochemical similarities, overeating and obesity may act as protective factors reducing drug reward and addictive behaviors. In animal models of addiction withdrawal from sugar induces imbalances in the neurotransmitters, acetylcholine and dopamine, similar to opiate withdrawal. Many human neuroimaging studies have supported the concept of linking food craving to drug craving behavior. Previously our laboratory coined the term Reward Deficiency Syndrome (RDS) for common genetic determinants in predicting addictive disorders and reported that the predictive value for future RDS behaviors in subjects carrying the DRD2 Taq A1 allele was 74%. While poly genes play a role in RDS, we have also inferred that disruptions in dopamine function may predispose certain individuals to addictive behaviors and obesity. It is now known that family history of alcoholism is a significant obesity risk factor. Therefore, we hypothesize here that RDS is the root cause of substituting food addiction for other dependencies and potentially explains this recently described Phenomenon (addiction transfer) common after bariatric surgery.

Citing Articles

Insights into the neurobiology of weight loss after bariatric surgery and GLP-1R agonists.

Cook T, Fuller K, Sandoval D Neuropharmacology. 2024; 265():110269.

PMID: 39675463 PMC: 11702201. DOI: 10.1016/j.neuropharm.2024.110269.


Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 Analogs.

Modestino E, Bowirrat A, Baron D, Thanos P, Hanna C, Bagchi D J Addict Psychiatry. 2024; 8(1):34-49.

PMID: 39618491 PMC: 11606528.


Self-Harm Before and Six Months After Obesity Surgery.

Thomas T, Tilk K, Klassen K, Pommnitz M, Wunder R, Mall J Obes Surg. 2024; 34(10):3579-3591.

PMID: 39134834 PMC: 11481644. DOI: 10.1007/s11695-024-07439-3.


Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.

Blum K, Baron D, Mclaughlin T, Thanos P, Dennen C, Ceccanti M J Addict Psychiatry. 2024; 8(1):1-33.

PMID: 38765881 PMC: 11100022.


Bariatric surgery and mental health outcomes: an umbrella review.

Law S, Dong S, Zhou F, Zheng D, Wang C, Dong Z Front Endocrinol (Lausanne). 2023; 14:1283621.

PMID: 38027159 PMC: 10653334. DOI: 10.3389/fendo.2023.1283621.


References
1.
Stice E, Yokum S, Bohon C, Marti N, Smolen A . Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4. Neuroimage. 2010; 50(4):1618-25. PMC: 3987805. DOI: 10.1016/j.neuroimage.2010.01.081. View

2.
Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B . Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett. 2006; 405(3):196-201. DOI: 10.1016/j.neulet.2006.07.030. View

3.
Hazzan D, Chin E, Steinhagen E, Kini S, Gagner M, Pomp A . Laparoscopic bariatric surgery can be safe for treatment of morbid obesity in patients older than 60 years. Surg Obes Relat Dis. 2006; 2(6):613-6. DOI: 10.1016/j.soard.2006.09.009. View

4.
Barnard N, Noble E, Ritchie T, Cohen J, Jenkins D, Turner-Mcgrievy G . D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition. 2008; 25(1):58-65. PMC: 2615385. DOI: 10.1016/j.nut.2008.07.012. View

5.
Kalarchian M, Marcus M, Levine M, Courcoulas A, Pilkonis P, Ringham R . Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007; 164(2):328-34. DOI: 10.1176/ajp.2007.164.2.328. View